Recently, Luo et al. reported in three different two-tumour mouse models that concurrent triple therapy with RT, anti-PD-1 and cisplatin resulted in significant enhancement of the abscopal effect via the CXCR3/CXCL10 axis as well as cisplatin-induced CD8+ T cells and cytoreductive effect [63]. This evidence concerns the gene PDCD1 and neoplasm.